Brief: Corvus Pharmaceuticals Posts Q4 Net Loss Of $0.21 Per Share

Corvus Pharmaceuticals

28/03/2023 23:35

March 28 (Reuters) - Corvus Pharmaceuticals Inc
 CRVS.O :
    * CORVUS PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
REPORTS
FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
    * CORVUS PHARMACEUTICALS INC- AS OF DECEMBER 31, 2022,
CORVUS HAD
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALING $42.3
MILLION
    * CORVUS PHARMACEUTICALS INC- BASED ON ITS CURRENT PLANS,
CORVUS
EXPECTS ITS CASH TO FUND OPERATIONS INTO 2024
    * CORVUS PHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE,
BASIC AND
DILUTED $0.21

Source text for Eikon:  ID:nGNX4YxcJj 
Further company coverage:  CRVS.O 

 ((Reuters.Briefs@thomsonreuters.com;))